PLSE
PULSE BIOSCIENCES, INC.
PULSE BIOSCIENCES, INC. (PLSE) has 6 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: May 15, 2026.
The most active filer is Chief Commercial Officer Danahy Kevin Patrick with 4 filings. Insiders have net bought $11.8M over the trailing 6 months. The largest single insider purchase in this window was $13.0M by Director, 10% Owner DUGGAN ROBERT W on May 11, 2026.
- Industry:Medical - Instruments & Supplies
- CEO:Paul Arthur LaViolette
- Employees:116
- HQ:Miami, FL, US
- IPO:2016-05-18
Insider Buying
$13.3M
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$2.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director, 10% Owner | Purchase | 660,233 | $13.0M | May 15 | SEC ↗ | |
| Chief Executive Officer | Purchase | 15,000 | $295K | May 12 | SEC ↗ | |
| Chief Commercial Officer | Sale | 5,000 | $118K | Feb 23 | SEC ↗ | |
Danahy Kevin PatrickFirst filing | Chief Commercial Officer | Sale | 20,000 | $467K | Feb 17 | SEC ↗ |
Danahy Kevin PatrickFirst filing | Chief Commercial Officer | Sale | 20,000 | $471K | Feb 17 | SEC ↗ |
Danahy Kevin PatrickFirst filing | Chief Commercial Officer | Sale | 20,000 | $473K | Feb 17 | SEC ↗ |
Related companies
PULSE BIOSCIENCES, INC. is in the Healthcare sector.